Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis
- 1 November 2013
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 169 (4), 262-270
- https://doi.org/10.1016/j.ijcard.2013.08.131
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Cost-Effectiveness Analysis for Surgical, Angioplasty, or Medical Therapeutics for Coronary Artery DiseaseCirculation, 2012
- Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal, 2010
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009
- Economic Impact of Angina After an Acute Coronary SyndromeCirculation: Cardiovascular Quality and Outcomes, 2009
- Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary SyndromesCirculation: Cardiovascular Quality and Outcomes, 2008
- Effect of PCI on Quality of Life in Patients with Stable Coronary DiseaseThe New England Journal of Medicine, 2008
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseThe New England Journal of Medicine, 2007
- Ranolazine for the Treatment of Chronic Angina and Potential Use in Other Cardiovascular ConditionsCirculation, 2006
- Angina 1 year after percutaneous coronary intervention: A report from the NHLBI Dynamic RegistryAmerican Heart Journal, 2002
- Incorporating variations in the quality of individual randomized trials into meta-analysisJournal of Clinical Epidemiology, 1992